Rotavirus Clinical Trial
Official title:
Immunogenicity and Safety of V260 in Healthy Infants in Korea
Immunogenicity and Safety of V260 in Healthy Infants in Korea
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02907216 -
Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants
|
Phase 4 | |
Completed |
NCT00496054 -
Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)
|
Phase 3 | |
Completed |
NCT03587389 -
Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam
|
Phase 4 | |
Unknown status |
NCT02177799 -
Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon
|
N/A | |
Completed |
NCT01871038 -
Rotarix Vaccine Effectiveness
|
N/A | |
Completed |
NCT03031743 -
The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan
|
N/A | |
Terminated |
NCT00836498 -
A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)
|
Phase 1 | |
Completed |
NCT02141204 -
Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants
|
Phase 3 | |
Enrolling by invitation |
NCT02153866 -
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine
|
Phase 4 | |
Completed |
NCT00820261 -
Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospital, Kenya
|
N/A | |
Completed |
NCT00718237 -
Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)
|
Phase 3 |